Healthcare media, data & commercial strategy
Strategy from both sides of the table.
I've spent 20 years on both sides of pharma media: buying it for brand teams, and building and pricing it for the companies that sell it. Limulus Advisory brings both views to your next decision.
How I help
Brand teams and their partners usually see half the picture.
Brand teams can't always see how a partner's product is built, priced, or where it will deliver. Partners can't always see how a brand team plans, evaluates and buys. Having worked in both seats, I help each side make better decisions about the other.
Get more from your media and data investments
- Media strategy & planningHCP and patient plans across non-personal promotion, point of care, pharmacy and search
- Partner evaluationAn outside view on which vendors, data and channels fit your brand's goals and budget
- Agency managementClearer scopes, sharper contract negotiations and QBRs that hold partners accountable
- Data & audience activationPutting HCP targeting and first-party data to work, with the change management to make it stick
Sell the way pharma buys
- Pricing & packagingPrice books, new-offering pricing and packaging built on how brand budgets work
- Product & go-to-market strategyPositioning and proof points that hold up with brand teams, agencies and procurement
- Revenue & yield strategyGetting the most value from your inventory, data and client relationships
- Client strategyAccount plans and executive-level advisory for your largest pharma relationships
Ways to work together
Senior experience, sized to the need.
Projects
Defined work with a clear deliverable, such as a pricing review, a media plan audit or a vendor evaluation.
Advisory retainer
A standing advisor for your leadership team, available for decisions, deal reviews and planning cycles.
Fractional leadership
Hands-on senior leadership for a set period while you build or rebuild a function.
About
Matt Gann, Founder
Matt has spent about 20 years in digital, data and media strategy across healthcare and pharma, on both the brand side and the partner side.
Most recently, he was Director, HCP Data & Audiences at IQVIA Digital. As Product Lead for HCP Audiences, he owned the product's pricing, including the price book and pricing for new offerings, and led a team of four.
Before IQVIA, Matt spent seven years at Novartis as an Associate Director supporting more than 15 oncology and pharma brands. As part of the Media Center of Excellence, he led non-personal promotion, point-of-care and pharmacy media and helped manage the media agency relationship. Earlier roles at Express Scripts, Citigroup, Metris, U.S. Bancorp and Price Waterhouse Consulting grounded him in PBM economics, analytics and client consulting.
Matt holds an MBA in Marketing from Indiana University's Kelley School of Business and a BS in Finance from the University of Delaware. He is based in Fenwick Island, Delaware.
- Novartis
- IQVIA Digital
- Express Scripts
- Indiana University Kelley MBA
Why "Limulus"?
Limulus polyphemus, the Atlantic horseshoe crab, has outlasted 450 million years of change, and every spring it comes ashore by the hundreds of thousands on the Delaware Bay, not far from where this practice is based. Its blood is also used to test injectable drugs for contamination, which makes it a quiet part of the pharma supply chain. It seemed like the right namesake for a durable, practical, healthcare-focused advisory.
Contact
Let's talk.
Tell me a little about what you're working on. I'll get back to you within one business day.
Prefer LinkedIn? Follow Limulus Advisory.